Actinium Pharmaceuticals Inc (ATNM)

[ANESRI]

pg 6 (broadening the use of Ac225!)

On September 30, 2014, the Company entered into a research agreement with the Albert Einstein College of Medicine of Yeshiva University (“Einstein”). According to the agreement, Einstein will use certain materials provided by the Company to complete a research project. The research project will explore the feasibility of using Actinium 225 to prepare patients with blood borne cancers to receive a hematopoietic stem cell transplant. Einstein will periodically provide the Company with reports showing project data or research. The total fixed price of the project is $0.2 million which is payable to Einstein in three payments.

During the nine months ended September 30, 2016 and 2015, the Company paid Einstein approximately $37,000 and $55,000, respectively in full of the agreement.